CAS-SRGN Trademark

Trademark Overview


On Monday, April 22, 2019, a trademark application was filed for CAS-SRGN with the United States Patent and Trademark Office. The USPTO has given the CAS-SRGN trademark a serial number of 88396357. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 2, 2020. This trademark is owned by Casebia Therapeutics Limited Liability Partnership. The CAS-SRGN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biological preparations, namely, proteins and nucleotide sequences for scientific and medical research

Medicinal preparations consisting of proteins and nucleic acid sequences for diagnosis and treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy and gene editing products, namely, therapeutic agents for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy and gene editing products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of gene...
cas-srgn

General Information


Serial Number88396357
Word MarkCAS-SRGN
Filing DateMonday, April 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 4, 2020

Trademark Statements


Goods and ServicesBiological preparations, namely, proteins and nucleotide sequences for scientific and medical research
Goods and ServicesMedicinal preparations consisting of proteins and nucleic acid sequences for diagnosis and treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy and gene editing products, namely, therapeutic agents for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy and gene editing products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, May 7, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 7, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCasebia Therapeutics Limited Liability Partnership
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB

Party NameCasebia Therapeutics Limited Liability Partnership
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB

Trademark Events


Event DateEvent Description
Monday, November 2, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 2, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 31, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 4, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, December 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 8, 2019NON-FINAL ACTION E-MAILED
Monday, July 8, 2019NON-FINAL ACTION WRITTEN
Thursday, June 27, 2019ASSIGNED TO EXAMINER
Tuesday, May 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 25, 2019NEW APPLICATION ENTERED IN TRAM